Literature DB >> 7108769

The metabolism of phenytoin by isolated hepatocytes and hepatic microsomes from male rats.

M Tsuru, R R Erickson, J L Holtzman.   

Abstract

Previous in vivo and in vitro studies have indicated that the Km for phenytoin hydroxylation is about 30 microM. Yet, the drug shows dose-dependent kinetics suggesting a Km of about 5 microM. The present studies indicate the discrepancy is not due to active transport of the drug in the hepatocyte or a decrease in the Km due to the low pO2 of the portal vein leading to uncompetitive inhibition. Studies in both hepatocytes and microsomes indicate the presence of a high affinity hydroxylase with a Km of 2 to 5 microM. These data suggest that this enzyme is the one primarily involved in the metabolism of phenytoin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7108769

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  3 in total

1.  A dispersion model of hepatic elimination: 2. Steady-state considerations--influence of hepatic blood flow, binding within blood, and hepatocellular enzyme activity.

Authors:  M S Roberts; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1986-06

2.  Inhibitors of alprazolam metabolism in vitro: effect of serotonin-reuptake-inhibitor antidepressants, ketoconazole and quinidine.

Authors:  L L von Moltke; D J Greenblatt; M M Cotreau-Bibbo; J S Harmatz; R I Shader
Journal:  Br J Clin Pharmacol       Date:  1994-07       Impact factor: 4.335

3.  Hepatic Bioactivation of Skin-Sensitizing Drugs to Immunogenic Reactive Metabolites.

Authors:  Lor Huai Chong; Celine Ng; Huan Li; Edmund Feng Tian; Abhishek Ananthanarayanan; Michael McMillian; Yi-Chin Toh
Journal:  ACS Omega       Date:  2019-08-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.